Cholecystokinin and the Regulation of Insulin Secretion

References

• Creutzfeldt W. The incretin concept today. Diabetologia 1979; 16: 75–85
   PubMed Web of Science ®Google Scholar
• Creutzfeldt W, Ebcrt R. New developments in the incretin concept. Diabetologia 1985; 28: 565–573
   PubMed Web of Science ®Google Scholar
• Ahrén B, Taborsky G J, Jr, Porte D, Jr. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia 1986; 29: 827–836
   PubMed Web of Science ®Google Scholar
• Rushakoff R J, Liddle R A, Williams J A, Goldfine I D. The role of cholecystokinin and other gut peptides on regulation of postprandial glucose and insulin levels. Insulin. Handbook of experimental pharmacology, P Cuatrecasas, S Jacobs. Springer Verlag, Berlin 1990; 92: 125–142
   Google Scholar
• Ahrén B, Lundquist I. Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion. Acta Diabetol Lat 1981; 18: 345–356
   PubMedGoogle Scholar
• Okabayashi Y, Otsuki M, Baba S. Cholecystokinin in the entero-insular axis. Diabet Res Clin Pract 1989; 7: S79–S85
   PubMed Web of Science ®Google Scholar
• Liddle R A, Goldfine I D, Rosen M S, Taplitz R A, Williams J A. Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985; 75: 1144–1152
   PubMed Web of Science ®Google Scholar
• Sundler F, Böttcher G. Islet innervation, with special reference to neuropeptides. The endocrine pancreas, E Samols. Raven Press, New York 1991; 29–52
   Google Scholar
• Larsson L-I. Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin/CCK immunoreactive nerves. J Histochem Cytochem 1979; 27: 1283–1284
   PubMed Web of Science ®Google Scholar
• Larsson L-I, Rehfeld J F. Peptidergic and adrenergic innervation of pancreatic ganglia. Scand J Gastroenterol 1979; 14: 433–437
   PubMed Web of Science ®Google Scholar
• Woods S C, Porte D, Jr. Neural control of the endocrine pancreas. Physiol Rev 1974; 54: 596–619
   PubMed Web of Science ®Google Scholar
• Miller R E. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocrine Rev 1981; 2: 471–494
   PubMed Web of Science ®Google Scholar
• Cantor P. Cholecystokinin in plasma. Digestion 1989; 42: 181–201
   PubMed Web of Science ®Google Scholar
• Cantor P, Rehfeld J F. The molecular nature of cholecystokinin in human plasma. Clin Chira Acta 1987; 168: 153–158
   PubMed Web of Science ®Google Scholar
• Dockray G J. Physiology of cholecystokinin in brain and gut. Br Med Bull 1982; 38: 253–258
   PubMed Web of Science ®Google Scholar
• Rehfeld J F, Larsson L-I, Goltermann N R, et al. Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature 1980; 284: 33–38
   PubMed Web of Science ®Google Scholar
• Dockray G J. The physiology of cholecystokinin in brain and gut. Br Med Bull 1982; 38: 253–258
   PubMed Web of Science ®Google Scholar
• Ahrén B, Hedner P, Lundquist I. Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse. Acta Pharmacol Toxicol 1986; 58: 115–120
   PubMedGoogle Scholar
• Sandberg E, Ahrén B, Tcndler D, Efendic S. Cholecystokinin (CCKJ-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationship. Pharmacol Toxicol 1988; 63: 42–45
   PubMedGoogle Scholar
• Verspohl E J, Ammon H PT, Williams J A, Goldfine I D. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes 1986; 35: 38–43
   PubMed Web of Science ®Google Scholar
• Okabayashi Y, Otsuki M, Ohki A, Sakamoto C, Baba S. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas. Endocrinology 1983; 113: 2210–2215
   PubMed Web of Science ®Google Scholar
• Hermansen K. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro. Endocrinology 1984; 114: 1770–1775
   PubMed Web of Science ®Google Scholar
• Ahrén B, Mårtensson H, Nobin A. Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig. Pancreas 1988; 3: 279–284
   PubMed Web of Science ®Google Scholar
• Otsuki M, Okabayashi Y, Ohki A, et al. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas. Am J Physiol 1986; 250: G405–G411
   Google Scholar
• Sakamoto C, Goldfine I D, Roach E, Williams J A. Localization of saturable CCK binding sites in rat pancreatic islets by light and electron microscope autoradiography. Diabetes 1985; 34: 390–394
   PubMed Web of Science ®Google Scholar
• Dourish C T, Hill D R. Classification and function of CCK receptors. Trends Pharmacol Sci 1987; 8: 207–208
   Web of Science ®Google Scholar
• Williams J A, Hallden G, McChesney D, Szecowka J, Logsdon C D, Goldfine I D. The cholecystokinin and gastrin receptors. Neuropeptides and their receptors, T W Schwartz, L M Hilsted, J F Rehfeld. Munksgaard, Copenhagen 1990; 310–319
   Google Scholar
• Reagan J E, Robinson J L, Lotti V J, Goldfine M E. Fasting and L-364,718 prevent cholecystokinin-induced elevations of plasma insulin levels. Eur J Pharmacol 1987; 144: 241–243
   PubMed Web of Science ®Google Scholar
• Karlsson S, Ahrén B. Effects of three different cholecystokinin-receptor antagonists on basal and stimulated insulin and glucagon secretion in mice. Acta Physiol Scand 1989; 135: 271–278
   PubMedGoogle Scholar
• Zawalich W S, Diaz V A, Zawalich K C. Stimulatory effects ol cholecystokinin on isolated perifused islets inhibited by potem and specific antagonist L 364718. Diabetes 1988; 37: 1432–1437
   PubMed Web of Science ®Google Scholar
• Karlsson S, Ahrén B. CCKA receptor antagonism inhibits mechanisms underlying CCK-8-stimulated insulin release in isolated rat islets. Eur J Pharmacol 1991; 202: 253–257
   PubMed Web of Science ®Google Scholar
• Chang R SL, Lotti V J. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci USA 1986; 83: 4923–4926
   PubMed Web of Science ®Google Scholar
• Evans B E, Bock M G, Rittle K E, et al. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc Natl Acad Sci USA 1986; 83: 4918–4922
   PubMed Web of Science ®Google Scholar
• Prentki M, Matschinsky F M. Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanism of insulin secretion. Physiol Rev 1987; 67: 1185–1248
   PubMed Web of Science ®Google Scholar
• Zawalich W S, Cote S B, Diaz V A. Influence of cholecystokinin on insulin output from isolated perifused pancreatic islets. Endocrinology 1986; 119: 616–621
   PubMed Web of Science ®Google Scholar
• Karlsson S, Ahrén B. Dependence on extracellular Ca2+ for the effects of cholecystokinin-8 in rat pancreatic islets. Diabetes Res 1991, In press
   PubMedGoogle Scholar
• Zawalich W, Takuwa N, Takuwa Y, Diaz V, Rasmussen H. Interactions of cholecystokinin and glucose in rat pancreatic islets. Diabetes 1987; 36: 426–433
   PubMed Web of Science ®Google Scholar
• Berridge M J. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 1984; 220: 345–360
   PubMed Web of Science ®Google Scholar
• Best L, Malaisse W J. Nutrient and hormone-neurotransmitter stimuli induce hydrolysis of polyphosphoinositides in rat pancreatic islets. Endocrinology 1984; 115: 1814–1820
   PubMed Web of Science ®Google Scholar
• Klosa M, Ammon H PT, Verspohl E J. Cholecystokinin-modulated phospholipid metabolism and phosphoinositide breakdown in rat pancreatic islets. Diabetologia 1988; 31: 508A
   Web of Science ®Google Scholar
• Florholmen J, Malm D, Vonen B, Burhol P G. Effect of cholecystokinin on the accumulation of inositol phosphates in isolated pancreatic islets. Am J Physiol 1989; 257: G865–G870
   Google Scholar
• Wollheim C B, Regazzi R. Protein kinase C in insulin releasing cells. Putative role in stimulus secretion coupling. FEBS Lett 1990; 268: 376–380
   PubMed Web of Science ®Google Scholar
• Jones P M, Persuad S J, Howell S L. Protein kinase C and the regulation of insulin secretion from pancreatic B cells. J Mol Endocrinol 1991; 6: 121–127
   PubMed Web of Science ®Google Scholar
• Hii C ST, Jones P M, Persuad S J, Howell S L. A re-assessment of the role of protein kinase C in glucose-stimulated insulin secretion. Biochem J 1987; 246: 489–493
   PubMed Web of Science ®Google Scholar
• Persuad S J, Jones P M, Sugden D, Howell S L. The role of protein kinase C in cholinergic stimulation of insulin secretion from rat islets of Langcrhans. Biochem J 1989; 264: 753–758
   PubMed Web of Science ®Google Scholar
• Karlsson S, Ahrén B. Cholecystokinin-stimulatcd insulin secretion and protein kinase C in rat pancreatic islets. Acta Physiol Scand 1991; 142: 397–403
   PubMedGoogle Scholar
• Persuad S J, Jones P M, Howell S L. Protein kinase C mediates cholecystokinin-8S stimulation of insulin release. Diabetologia 1991; 34: A25, Suppl 2
   Google Scholar
• Henquin J C. Regulation of insulin release by ionic and electrical events in B cells. Hormone Res 1987; 27: 168–178
   PubMedGoogle Scholar
• Verspohl E J, Breuning I, Ammon H PT, Mark M. Significance of Ca2+, Rb+, of cAMP and cGMP for the CCK8-modulated insulin release. Regul Pept 1987; 17: 229–241
   PubMedGoogle Scholar
• Hedeskov C J. Mechanisms of glucose-induced insulin secretion. Physiol Rev 1980; 60: 442–509
   PubMed Web of Science ®Google Scholar
• Zawalich W S, Diaz V A, Zawalich K C. Influence of cyclic AMP and calcium on [3H]-inositol efflux, inositol phosphate accumulation and insulin release from isolated rat islets. Diabetes 1988; 37: 1478–1483
   PubMed Web of Science ®Google Scholar
• Sakamoto C, Otsuki M, Ohki A, et al. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas. Endocrinology 1982; 110: 398–402
   PubMed Web of Science ®Google Scholar
• Verspohl E J, Breuning I, Ammon H PT. Effect of CCK-8 on pentose phosphate shunt activity, pyridine nucleotides, and glucokinase of rat islets. Am J Physiol 1989; 256: E68–E73
   Google Scholar
• Peter-Riesch B, Fathi M, Schlegel W, Wollheim C B. Glucose and carbachol generate 1,2-diacylglycerols by different mechanisms in pancreatic islets. J Clin Invest 1988; 81: 1154–1161
   PubMed Web of Science ®Google Scholar
• Wolf B A, Easom R A, Hughes J H, McDaniel M L, Turk J. Secretagogue-induced diacylglycerol accumulation in isolated pancreatic islets. Mass spectrometric characterization of the fatty acyl content indicates multiple mechanisms of generation. Biochemistry 1989; 28: 4291–4301
   PubMed Web of Science ®Google Scholar
• McIntyre N, Holdsworth D C, Turner D S. New interpretation of oral glucose tolerance. Lancet 1964; 2: 20–21
   PubMed Web of Science ®Google Scholar
• Raptis S, Dollinger H C, Schroder K E, Schleyer M, Rothenbuchner G, Pfeiffer E F. Differences in insulin, growth hormone and pancreatic enzyme secretion after intravenous and intraduodenal administration of mixed amino acids. N Engl J Med 1973; 228: 1199–1202
   Web of Science ®Google Scholar
• Kreymann B, Gathei M A, Williams G, Bloom S R. Glucagonlike peptide-1 7–36: a physiological incretin in man. Lancet 1987; 2: 1300–1303
   PubMed Web of Science ®Google Scholar
• Liddle R A, Green G M, Conrad C K, Williams J A. Proteins but not amino acids or fats stimulate cholecystokinin secretion in the rat. Am J Physiol 1986; 251: G243–G248
   PubMed Web of Science ®Google Scholar
• Rosetti L, Shulman G I, Zawalich W S. Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding. Diabetes 1987; 36: 1212–1215
   PubMed Web of Science ®Google Scholar
• Rushakoff R J, Goldfine I D, Carter J D, Liddle R A. Physiological concentrations of cholecystokinin stimulate amino-acid induced insulin release in humans. J. Clin Endocrinol Metab 1987; 65: 395–401
   Google Scholar
• Hildebrand P, Ensinck J W, Mossi S, Delco F, Gyr K, Beglinger C. Cholecystokinin (CCK) is not an incretin in humans. Digestion 1990; 46: 143–144
   Google Scholar
• Ahrén B, Pettersson M, Uvnäs-Moberg K, Gutniak M, Efendic S. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Diabetes Res Clin Pract 1991; 13: 153–162
   PubMed Web of Science ®Google Scholar
• Liddle R A, Gertz B J, Kanayama S, et al. Regulation of pancreatic endocrine function by cholecystokinin: Studies with MK-329, a nonpeptide cholecystokinin receptor antagonist. J Clin Endocrinol Metab 1990; 70: 1312–1318
   PubMed Web of Science ®Google Scholar
• Nauck M, Härter S, Ebert R, Creutzfeldt W. Effects of four orally administered analogues of prostaglandin E1 and E2 on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man. Eur J Clin Invest 1989; 19: 298–305
   PubMed Web of Science ®Google Scholar
• Zawalich W S. Synergistic impact of cholecystokinin and gastric inhibitory polypeptide on the regulation of insulin secretion. Metabolism 1988; 37: 778–781
   PubMed Web of Science ®Google Scholar
• Ahrén B, Hedner P, Lundquist I. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice. Acta Endodrinol 1983; 102: 96–102
   PubMed Web of Science ®Google Scholar
• Fujimoto W Y, Williams R H, Ensinck J W. Gastric inhibitory polypeptide, cholecystokinin, and secretin effects on insulin and glucagon secretion by islet cultures. Proc Soc Exp Biol Med 1979; 160: 349–353
   PubMed Web of Science ®Google Scholar
• Fehman H-C, Göke B, Weber V, et al. Interaction of glucagon-like peptide-1 (7–36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas. Pancreas 1990; 5: 361–365
   PubMed Web of Science ®Google Scholar
• Nauck M, Schmidt W E, Ebert R, et al. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: Interactions with glucose, phenylalanine, and cholecystokinin-8. J Clin Endocrinol Metab 1989; 69: 654–662
   PubMed Web of Science ®Google Scholar
• Liddle R A, Rushakoff R J, Morita E T, Beccaria L, Carter J D, Goldfine I D. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. J Clin Invest 1988; 81: 1675–1681
   PubMed Web of Science ®Google Scholar
• Hosotani R, Chowdhury P, Huang Y-S, Rayford P L. Neural mechanisms of pancreatic polypeptide release in conscious dogs. Am J Physiol 1989; 257: G134–G137
   Google Scholar
• Karlsson S, Ahrén B. Peptide receptor antagonists in the study of insulin and glucagon secretion in mice. Eur J Pharmacol 1990; 191: 457–468
   PubMed Web of Science ®Google Scholar
• Otsuki M, Okabayashi Y, Nakamura T, et al. Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas. Dig Dis Sci 1987; 32: 1136–1144
   PubMed Web of Science ®Google Scholar